Transparent Sharing of Digital Health Data: A Call to Action.
Link to full article here
There are no clinical practice recommendations.
The Chair (and Vice-Chair) of the document is free of any relationships with industry and other entities (RWIs).
The remainder of the writing committee may have RWIs, with no dollar limit, but may not have relevant stock, stock options, equity, or royalties or be employed by industry.
The writing committee is encouraged to gain information from advisors. Advisors must be physicians or health care providers who are not able to serve as writing committee members because they have relevant stock, stock options, equity, royalties, or other relationships that may be determined to create conflict of interest. Advisors cannot be employed by industry and do not participate in writing.
The writing committee uses industry forums to engage representatives of industry, the U.S. Food and Drug Administration, or other third-party organizations in a dialogue to provide an exchange of information.
A full disclosure of RWIs for each writing committee member and each advisor is provided in an appendix.
Photography by John Schnobrich